Robles BioCeutics partners with Innovigen to manufacture GlowSelle

This partnership propels Robles BioCeutics’ position as a pioneering company bridging advanced stem cell science with dermatological product innovation.

USA – Robles BioCeutics, a science-driven regenerative dermatology company, has teamed up with Innovagen, a California-based formulation and production expert specializing in cellular and cosmetic GMP manufacturing, to bring its flagship product, GlowSelle, to market. 

GlowSelle™ is an innovative regenerative skincare product developed using cutting-edge stem cell technology designed to rejuvenate, restore, and protect the skin. 

The product aims to combat visible signs of ageing such as fine lines, wrinkles, and loss of elasticity by boosting collagen production and enhancing skin vitality for a radiant, firm, and youthful complexion. 

The formulation has been created in collaboration with dermatology and biotechnology experts to ensure high efficacy suitable for a broad range of skin types, including sensitive and mature skin.

Maria Robles, CEO and Founder of Robles BioCeutics, emphasized the intentional selection of Innovagen as a partner, stating, “We’ve been very intentional about selecting a partner who shares our commitment to innovation, transparency, and results-driven formulation.”

“Innovigen brings not only technical excellence, but also the flexibility and vision needed to help us deliver a product that reflects the future of anti-ageing skincare.”

The partnership focuses on refining, scaling, and manufacturing GlowSelle as well as future product lines, leveraging Innovigen’s expertise in advanced formulation, quality control, regulatory compliance, ingredient sourcing, batch production, packaging, and quality assurance.

Under the agreement, Innovagen will provide comprehensive contract manufacturing services for GlowSelle and potential future skin care lines. 

This includes joint development on formulation refinement, scale-up production, ingredient sourcing guidance, packaging, quality assurance, and meeting regulatory standards. 

In addition, both companies plan to explore co-development opportunities for next-generation skincare products rooted in regenerative science and biotechnology, with a shared emphasis on maintaining confidentiality and protecting proprietary information throughout their collaboration.

This partnership propels Robles BioCeutics’ position as a pioneering company bridging advanced stem cell science with dermatological product innovation, aiming to deliver transformative skincare solutions that not only target ageing but promote overall skin health and regeneration.

 Innovigen Inc. is a contract manufacturer specializing in biotech-driven cosmetic formulation and GMP-grade cell culture media. 

It supports brands with end-to-end services from ingredient sourcing to packaging, focused on regenerative skincare.

Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.

Newer Post

Thumbnail for Robles BioCeutics partners with Innovigen to manufacture GlowSelle

Symrise AG appoints Michael Friede as President of Scent & Care segment

Older Post

Thumbnail for Robles BioCeutics partners with Innovigen to manufacture GlowSelle

MyMicrobiome unveils new standard for Eczema-Prone Skin